title: Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.
authors.forename: R
authors.initials: R
authors.lastname: Goldberg
authors.forename: E
authors.initials: E
authors.lastname: Smith
authors.forename: S
authors.initials: S
authors.lastname: Bell
authors.forename: A
authors.initials: A
authors.lastname: Thompson
authors.forename: P V
authors.initials: PV
authors.lastname: Desmond
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D017809:Fatal Outcome; D006509:Hepatitis B / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib